Eleven residents from Marblehead will participate in the Boston Marathon Jimmy Fund Walk presented by Hyundai on Sunday, Oct. 6.
The residents from Marblehead include Tricia (Pat) Donovan McLeod, John Marco, Emilia Marco, Mia Klein, Danielle Devlin, Dennis King, Annie Marco, Rachel Marco, Patrick Devlin, Clover Reed, and one other resident. They will walk alongside thousands of others to participate in the iconic annual event that will unite the community to raise funds to support all forms of adult and pediatric care and research at the nation’s premier cancer center, Dana-Farber Cancer Institute.
The Jimmy Fund Walk has raised more than $176 million for Dana-Farber in its 35-year history, raising a record-breaking $9.4 million in 2023.
“For 35 years, the Jimmy Fund Walk has continuously supported lifesaving research and cancer care at Dana-Farber. Our goal is to build off of the momentum we’ve established throughout that history, and in 2024, aim to surpass our total from last year by raising $9.5 million,” Caitlin Fink, assistant vice president of event fundraising, said. “Fighting cancer is what we do. The walk unites our community under a common goal — to defy cancer together.”
One Walk, Four Distances, For All Cancers
The Jimmy Fund Walk is the only organized walk permitted to use the famed Boston Marathon course, and participants have the flexibility to choose from four distance options: 5K walk (from Dana-Farber’s Longwood Medical Campus); 10K walk (from Newton); half-marathon walk (from Wellesley); and marathon walk (from Hopkinton). Walkers can participate virtually as well.
Whatever route participants choose, they will be supported by hundreds of volunteers and treated to refueling stations with refreshments throughout the course. Poster-sized photographs of patients — Jimmy Fund Walk Heroes — are the heart of the event and appear along the course as inspiration. All routes will conclude at the Jimmy Fund Walk Finish Line powered by Schneider Electric at Boston Common, by the corner of Charles and Beacon Street. Finish-line activities will include a celebration with food, entertainment, and more.
To register for the Walk (#JimmyFundWalk) or to support a walker, visit www.JimmyFundWalk.org or call (866) 531-9255. Registrants can enter the promo code NEWS for $5 off the registration fee. All registered walkers will receive a bib, medal, and Jimmy Fund Walk T-shirt.
About the Jimmy Fund
The Jimmy Fund is comprised of community-based fundraising events and other programs that, solely and directly, benefit Dana-Farber Cancer Institute’s lifesaving mission to provide compassionate patient care and groundbreaking cancer research for children and adults. The Jimmy Fund is an official charity of the Boston Red Sox, the Massachusetts Chiefs of Police Association, the Pan-Mass Challenge, and the Variety Children’s Charity of New England. Since 1948, the generosity of millions of people has helped the Jimmy Fund save countless lives and reduce the burden of cancer for patients and families worldwide. Follow the Jimmy Fund on Facebook, X, and Instagram: @TheJimmyFund.
About Dana-Farber Cancer Institute
Dana-Farber Cancer Institute is one of the world’s leading centers of cancer research and treatment. Dana-Farber’s mission is to reduce the burden of cancer through scientific inquiry, clinical care, education, community engagement, and advocacy. Dana-Farber is a federally designated Comprehensive Cancer Center and a teaching affiliate of Harvard Medical School.
The institute provides the latest treatments in cancer for adults through Dana-Farber Brigham Cancer Center and for children through Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. Dana-Farber is the only hospital nationwide with a top-five U.S. News & World Report Best Cancer Hospital ranking in both adult and pediatric care. As a global leader in oncology, Dana-Farber is dedicated to a unique and equal balance between cancer research and care, translating the results of discovery into new treatments for patients locally and around the world, offering more than 1,100 clinical trials.